These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6771905)

  • 1. Platelet inhibitors in human renal homotransplantation: randomized comparison of aspirin versus dipyridamole.
    Kauffman HM; Adams MB; Hebert LA; Walczak PM
    Transplant Proc; 1980 Jun; 12(2):311-4. PubMed ID: 6771905
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of transplant renal artery stenosis.
    Kauffman HM; Sampson D; Fox PS; Doyle TJ; Maddison FE
    Surgery; 1977 Feb; 81(2):161-7. PubMed ID: 319550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal artery stenosis following transplantation: a response.
    Kauffman HM
    Surgery; 1979 May; 85(5):599. PubMed ID: 373153
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of anti-thrombotic therapy in renal disease.
    Kincaid-Smith P
    Scand J Haematol Suppl; 1979; 34():83-9. PubMed ID: 384508
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.
    George CR; Slichter SJ; Quadracci LJ; Kenny GM; Dennis MB; Striker GE; Harker LA
    Transplantation; 1975 Sep; 20(3):237-40. PubMed ID: 1099729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants.
    Kincaid-Smith P
    Lancet; 1969 Nov; 2(7627):920-2. PubMed ID: 4186594
    [No Abstract]   [Full Text] [Related]  

  • 7. Dipyridamole plus aspirin and hemodialysis graft patency.
    Hentschel DM
    N Engl J Med; 2009 Aug; 361(7):720-1; author reply 721. PubMed ID: 19681176
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin and dipyridamole for the secondary prevention of stroke.
    Zielinski R; French L
    J Fam Pract; 1999 Feb; 48(2):92. PubMed ID: 10037534
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: a cost-effectiveness analysis.
    Shah H; Gondek K
    Clin Ther; 2000 Mar; 22(3):362-70; discussion 360-1. PubMed ID: 10963290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
    Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
    Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation.
    Murphy GJ; Taha R; Windmill DC; Metcalfe M; Nicholson ML
    Br J Surg; 2001 Feb; 88(2):261-6. PubMed ID: 11167878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet drugs in cardiovascular prevention: take adverse effects and costs into account.
    Prescrire Int; 2000 Jun; 9(47):82-3. PubMed ID: 11010748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone?
    Hoover PL; Mold JW
    J Okla State Med Assoc; 2008 May; 101(5):80-2. PubMed ID: 18678202
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination of acetylsalicylic acid with dipyridamole is better than acetylsalicylic acid monotherapy].
    Schindler B
    Med Monatsschr Pharm; 2006 Nov; 29(11):421-3. PubMed ID: 17131692
    [No Abstract]   [Full Text] [Related]  

  • 17. Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?
    Dalton B; Papoushek C; Evans MF
    Can Fam Physician; 2001 Nov; 47():2235-9. PubMed ID: 11768921
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection.
    Anderson M; Dewar P; Fleming LB; Hacking PM; Morley AR; Murray S; Swinney J; Taylor RM; Uldall PR; Wardle EN
    Clin Nephrol; 1974; 2(3):93-9. PubMed ID: 4603996
    [No Abstract]   [Full Text] [Related]  

  • 19. Dipyridamole plus aspirin in cerebrovascular disease.
    Cohen SN
    Arch Neurol; 2000 Jul; 57(7):1086-7. PubMed ID: 10892000
    [No Abstract]   [Full Text] [Related]  

  • 20. [No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Dec; 137(51):2669. PubMed ID: 8278004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.